The clinical drug psoralen, in the presence of 360-nm light, binds to cellular DNA, forming monofunctional adducts with pyrimidine bases and interstrand cross-links. Cross-links, however, rather than monoadducts, appear to be the DNA lesion primarily responsible for the sensitizing action of this drug. Formation of an interstrand cross-link necessarily damages both DNA strands at nearly the same point along the helical axis. Such a genetic defect would appear to be a formidable obstacle to cellular repair enzymes responsible for maintaining the integrity of DNA. If left unrepaired, a cross-link might prevent separation of the complementary strands during the next cycle of replication. Cells, however, are apparently able to reproduce normally after treatments which produce many cross-links in the DNA of each cell.
